- Home
- IRMD vs OPK Comparison
IRMD vs OPK Comparison
Compare IRMD & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IRMD | OPK |
|---|---|---|
| Founded | 1992 | 2006 |
| Country | United States | United States |
| Employees | 166 | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2014 | 2011 |
Fundamental Metrics
Financial Performance| Metric | IRMD | OPK |
|---|---|---|
| Price | $92.02 | $1.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $116.00 | $1.60 |
| AVG Volume (30 Days) | 109.3K | ★ 4.6M |
| Earning Date | 05-01-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | $83,814,000.00 | ★ $606,879,000.00 |
| Revenue This Year | $12.38 | N/A |
| Revenue Next Year | $11.31 | $4.24 |
| P/E Ratio | $106.06 | ★ N/A |
| Revenue Growth | ★ 14.43 | N/A |
| 52 Week Low | $67.84 | $0.98 |
| 52 Week High | $107.90 | $1.73 |
Technical Indicators
Market Signals| Indicator | IRMD | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 42.18 | 49.40 |
| Support Level | $90.96 | $1.25 |
| Resistance Level | $97.63 | $1.41 |
| Average True Range (ATR) | 3.10 | 0.09 |
| MACD | -0.50 | 0.01 |
| Stochastic Oscillator | 18.99 | 27.43 |
Price Performance
Historical ComparisonAbout IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.